XFOR

X4 Pharmaceuticals, Inc.

1.01 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

X4 Pharmaceuticals, Inc. stock is up 21.69% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 5 March’s closed higher than February.

About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor. The company is also developing X4P-002, a CXCR4 antagonist for the. treatment of brain cancers.